Cellectar Biosciences Inc. – Filings and Transcripts

NASDAQ: CLRB
Share price (6/3/26): $2.60
Market cap (6/3/26): $20.8 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement

Initial registration of new securities – amended

Initial registration of new securities

Prospectus supplement for primary offering

Prospectus supplement

Ownership Filter

Stonepine Capital Management, LLC

Bleichroeder LP

Rosalind Advisors, Inc.

News Filter

Change in Directors, Officers or Compensation

Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements or Exhibits

Reports Financial Results for Year Ended 2025 and Provides Corporate Updates

Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC